Preparation for treating feline hemobartonellosis and method for its application

FIELD: veterinary science.

SUBSTANCE: as an etiotropic substance the suggested preparation contains veribene to be injected intramuscularly once at the dosage of 4.8-5.2 mg/kg body weight. Both preparation and method of its application provide decreased multiplicity of injection.

EFFECT: shortened terms of therapy.

2 cl, 2 ex


The invention relates to veterinary medicine, namely to the drug, affecting organisms species hemobartonella, and treatment of hemobartonella cats using the drug.

It is known that for the treatment of hemobartonella cats use antibiotics - tetracycline at a dose of 10-20 mg/kg three times a day or doxycycpine from 5 to 10 mg/kg twice a day (I.E. Foley et al, 1998; F. Duba, 1999; Apparatchik, Avidin, 2000). Tetracycline is bacteriostatic drugs. The disadvantage of these tools is long lasting up to 2-3 weeks time and that they do not cause the complete elimination of the pathogen from the body, as well as with long-term use have hepatotoxic effects and have the ability to form a dysbacteriosis of the intestine.

Known group of drugs based on diminazine of acuurate: Aiden, berenil, verian and how they can be applied when blood parasite diseases of animals (Timofeev B.A., Karpenko I.G. Chemotherapy of protozoal diseases of farm animals // M: Rosselchozizdat. - 1977. - P.37, 42, 44, 47, 80). Drugs active against prokaryotic and eukaryotic microorganisms, including Babesia, Trypanosoma, Teleri, eperythrozoon. The drugs are based on the inhibition of aerobic glycolysis and DNA synthesis in pathogenic protozoa. Drugs used to treat large what about the cattle, sheep, horses, and dogs with protozoal diseases (trypanosomiasis, piroplasmosis, babesiosis). How to use: the dose of 3.5 mg/kg in aqueous solution and parenteral (Veterinary drugs in Russia: a Handbook / Irakleiou, Nuarimol. - M.: Selhozizdat, 2000. - S-250. Veterinary legislation, volume 3, - s). The disadvantage of the described tools is the lack of data on its use in hemobartonella cats and tested dosages.

The closest solution adopted for the prototype, is the use of verbena for the treatment of eperythrozoonosis animal diseases caused by the pathogen, located in the same taxonomic family with pathogen hemobartonella cats. In one gram of verbena contains 445 mg diazoamino-dibenzylidene of deaurata and auxiliary componenti. The drug is a fine-grain powder yellow, use a freshly prepared aqueous solutions of 7% concentration. To prepare the solution to a 2.36 g of granulated berenil add 12.5 ml of water and injected into the deep layer of muscles of the animal at a dose of 0.05 ml/kg (deacons, L.P. Test drugs for the treatment of lambs, patients eperythrozoonosis // Proceedings of the annual conference of VIEW / Moscow. - 1966. - .183; Slipchenko, S. the Treatment of sheep with mixed invasion of anaplasmosis and is of pericratonic // Scientific proceedings of Stavropol: Kai. - 1971. - 4. - S-129; Determinant of pathogenic bacteria Berga // Reference / M, 1980; Veterinary drugs in Russia: a Handbook / Irakleiou, Nuarimol. - M: Selhozizdat, 2000. - P.24-248).

The disadvantage is the lack of data on use of medication for the treatment of hemobartonella cats.

The technical problem solved by this invention is to expand the range of tools and methods for the treatment of hemobartonella cats.

The goal of the project is achieved in that in a well-known medication for the treatment of hemobartonella cats, including causal substance, according to the invention as a causal means use verian.

The goal of the project is achieved by the fact that in the known method of treatment of hemobartonella cats, including intramuscular medications sick animals, according to the invention the animals injected verian once, at a dose of 4.8-5.2 mg per 1 kg of weight.

The technical result of the present invention is to reduce the multiplicity of the introduction of drugs and the reduction of treatment time of hemobartonella cats.

With its high efficiency, this product has several disadvantages. The introduction of verbena weakened and malnourished animals can cause intoxication, manifested in strong anxiety, diarrhea,followed by depression.

Example 1. For the treatment used a 7% solution of verbena. Preparation of the solution was carried out immediately prior to use.

The study was conducted on 19 kittens 1.5 to 2.5 months of age, weighing 700-800 g, distributed in 2 experimental and control groups. After 15-20 days of quarantine kittens was intramuscularly injected with heparinised blood from spontaneously infected N. felis cats with acute flow hemobartonella and parasitemia 80%.

Verian was injected intramuscularly 4,8-5,2 mg/kg (once) in the form of a 7% solution of 7-12 day after infection with parasites of 15-20%.

100% kittens, which verian was administered at a dose of 4.8-5.2 mg/kg in 24 hours and in subsequent studies of blood parasites were not found. Improving the General condition of the kittens came in two days later. Held on the 30th day splenectomy did not lead to the emergence of hemobartonella in the blood and relapse within 30 days of the observation.

Kittens control group parasitemia was kept at the level of 3-50%. Two kittens were killed on 5-th and 11-th day from the moment of their infection. Three surviving kittens were severely depleted and significantly lagged in growth and development.

Example 2. When using verbena at a dose of 5 mg per 1 kg of weight, the cats of different ages (from 1 year to 10 years), diagnosed with hemobartonella the ez (n=46).

After the introduction watched the General condition of the animals. In the three cases noted signs of isidingo psychosis. The release of the body from pathogens and improvement occurred on 2-3rd day after application of verbena. 15 days after treatment, the animals of the pathogen was not identified.

Thus, aqueous injection solutions of verbena at a dose of 4.8-5.2 mg/kg are 100% effective against N. felis and can be used in practicing veterinary doctors for the treatment of patients with hemobartonella cats.

1. Drug for the treatment of hemobartonella cats containing causal substance, characterized in that as the final product contains verian.

2. A method of treating hemobartonella cats, including intramuscular them a drug, characterized in that the cats enter verian once, at a dose of 4.8-5.2 mg per 1 kg of weight.


Same patents:

FIELD: veterinary science.

SUBSTANCE: the present innovation deals with overall treatment of velvet antlers with chemical preparation due to spraying in case of loose movement of animals through their pen as a corridor open from both sides, as preparation one should apply "Butox" at deltametrin concentration being 0.002-0.003% and dosage being 250-350 ml/animal.

EFFECT: higher efficiency.

3 ex, 2 tbl

FIELD: veterinary science.

SUBSTANCE: the present innovation deals with overall treatment of velvet antlers with chemical preparation due to spraying in case of loose movement of animals through their pen as a corridor open from both sides, as preparation one should apply "Butox" at deltametrin concentration being 0.002-0.003% and dosage being 250-350 ml/animal.

EFFECT: higher efficiency.

3 ex, 2 tbl

FIELD: veterinary science.

SUBSTANCE: the suggested preparation is being the solution of either avermectines or their derivatives in organic solvents or their mixtures at concentration of 1-35 g/100 ml; as organic solvents the preparation contains benzyl alcohol, ethanol, triethylene glycol, dimethylsulfoxide or their mixtures. This preparation provides in case of needle-free injection the development of "depot" of active substance. Moreover, the latter practically does not enter milk, so the preparation could be applied for treating lactating cows.

EFFECT: higher efficiency of needle-free injection technique.

1 cl, 2 dwg, 3 tbl

Endoparasitic agent // 2250779

FIELD: medicine.

SUBSTANCE: invention relates to endoparasitic agent containing cyclic depsipeptide of general formula 1 and piperazine of formula 2 .

EFFECT: endoparasitic agent with synergetic agent.

6 cl, 7 ex, 7 tbl

FIELD: medicine, medicinal parasitology.

SUBSTANCE: the present innovation deals with affecting the helminthes with curative mixture made out of eucalyptus leaf at addition of eucalyptus essential oil. Curative mixture at the quantity of 1 l at 40-42 C should be daily introduced into patient's rectum with enemas for 5-7 d at intestinal keeping for 15-20 min. Before introducing the curative mixture it is necessary to apply purifying enema. The method suggested provides removal of different types of helminthes at excluding toxic action upon human body.

EFFECT: higher efficiency of helminthic removal.

3 ex

FIELD: medicine.

SUBSTANCE: invention proposes an agent for treatment of toxoplasmosis. Agent represents willow bark an aqueous extract prepared by method of thermal treatment in the ratio bark : water = 1:10, or willow bark powder. Invention expands assortment of agents of indicated prescription and provides treatment of patients with toxoplasmosis being among them with prevalent myocardium damage.

EFFECT: valuable medicinal properties of agent.

2 ex

FIELD: organic chemistry, chemical technology, insecticides.

SUBSTANCE: invention describes new compounds of the formula (X): wherein R1 means -CH2-Het; R means unsubstituted (C1-C20)-alkyl or (C1-C20)-alkyl that is substituted with one or some phenyls, or it means unsubstituted phenyl or phenyl substituted with (C1-C6)-alkyl, or it means (C1-C6)-alkyl that is substituted with cyclohexyl or means unsubstituted (C3-C7)- cyclohexyl or substituted with one or some substitutes taken among the group including halogen atom and (C1-C6)-alkyl, or it means biphenyl, or phenoxyphenyl; T and U each means independently from one another (C1-C6)-alkyl; R2, R'2 mean hydrogen atom; Het means pyridyl that is substituted with halogen atom. Also, invention describes a method for preparing compound of the formula (X) by interaction of compound of the formula (XX) with acid R-COOH and isolation of the end product from reaction mixture wherein substitutes R, R1, R2, R'2, T and U have values indicated for the formula (X); Hal means halogen atom. Also, invention describes a parasiticidal composition for control of blood-sucking insects. Invention provides preparing compounds eliciting parasiticidal activity with expressed prolonged effect.

EFFECT: improved preparing method, valuable properties of compounds and composition.

11 cl, 8 tbl, 8 ex

The invention relates to agriculture, in particular for veterinary helminthology, and can be used for the treatment of castadot and fasciolosis in ruminants

The invention relates to the field of pharmaceutical industry and relates to a treatment for scabies
The invention relates to the field of creation of deworming drugs of plant origin

FIELD: organic chemistry, pharmaceutical industry.

SUBSTANCE: invention relates to clathrate of azithromycin hydrate with 1,2-propyleneglycol of formula I , wherein m =1-2 and n = 0.20-0.40. Method for production of target compound includes azithromycin dissolution in acetone followed by addition of 1,2-propyleneglycol and water in solution, formed crystal filtering, washing with water and drying. Also disclosed is pharmaceutical composition for microbial infection treatment based on clathrate of formula I.

EFFECT: azithromycin with reduced hygroscopicity and increased storage stability.

7 cl, 7 dwg, 2 tbl, 4 ex

FIELD: pharmaceutical industry, medicine.

SUBSTANCE: invention relates to compounds of formula I , wherein A, L, Y, and k are as defined in specification. Compounds of formula I have value pharmacological activity, in particular potent antithrombosis action and are useful in treatment and prophylaxis of cardiovascular diseases such as thromboembolia. They represent also reversible inhibitors of factor X and factor VIIa (blood coagulation enzymes). Also disclosed are methods for production of compounds I, uses thereof, in particular as active ingredients in pharmaceutical compositions, as well as medicines containing the same.

EFFECT: new pharmaceutical compositions for treatment and prophylaxis of cardiovascular diseases.

10 cl, 50 ex

FIELD: veterinary science.

SUBSTANCE: animals should be introduced with antihistamine serum (AHS) subcutaneously at the dosage of 4.0-5.0 ml in combination with myxoferon at the quantity of 60-75 dosages and vitamin C at the dosage of 1.0-1.5 ml/animal, once daily, thrice at interval of 5-7 d. Application of AHS in combination with myxoferon and ascorbic acid provides active stimulation of immunological reactivity, increases total body resistance I animals and causes no toxic effects and allergic reactions.

EFFECT: higher efficiency of correction.

3 tbl

FIELD: gastroenterology.

SUBSTANCE: eradication of infection Heliobacter pylory in stomach comprises oral administration of corresponding drugs in powdered form mixed with orange juice. In particular, mixture of colloidal bismuth subcitrate (De-nol), Nifuratel (Macmirror), and Amoxycyllin (Flemoxin solutab) are used. Administration is performed on an empty stomach at least 30-40 min before the food intake. Patient then lies at least 30 min on the both sides alternatively.

EFFECT: suppressed water-repellent property of near-wall layer of stomach mucus and slowed down evacuation of liquid from stomach thereby ensuring fast diffusion of therapeutical substances into infect persisting zone and, therefore, direct bactericidal effect on Heliobacter pylory.

4 cl

FIELD: organic chemistry, pharmaceutical industry, medicine.

SUBSTANCE: invention relates to new derivatives of S-substituted N-1-[(hetero)aryl]alkyl-N'-1-[(hetero)aryl]alkylisothioureas of general formula I

in form of free base and salts with pharmaceutically accepted acids, as well as racemate, individual optical isomers or mixture thereof. In formula R1, R2, R3, R4, Y and Z are as described in specification. Compounds of present invention are capable to potentiate (positively modulate) AMPA/KA glutamate receptors and simultaneously to block transmembrane currents induced by activation of NMDA glutamate receptors. Also disclosed are method for production of said compounds, including optical isomers; pharmaceutical composition; method for investigation of glutamatergic system, and method for Alzheimer's disease, treatment; as well as method for extreme retentiveness of memory by administering of effective amount of claimed compounds.

EFFECT: new pharmaceutically active compounds for Alzheimer's disease treatment.

23 cl, 1 tbl, 11 ex

FIELD: medicine, gastroenterology.

SUBSTANCE: traditional eradication therapy should be supplemented with licopid at the dosage of 10 mg per os once daily before breakfast for 10 d. The present innovation prevents transfer of microorganisms into inactive form, accelerates restoration of mucosal epithelial layer in gastroduodenal area, provides complete eradication of microorganisms, that in its turn, favors to prevent disease exacerbation and restoration of gastroduodenal functions.

EFFECT: higher efficiency of therapy.

3 dwg, 2 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: the suggested composition includes compounds of natural ethers in cancer of mammalian soft tissues (including, the man), for example, in case of diseases of mammary gland. Both dosage and frequency of introduction depending upon a certain symptomatics could be decreased up to the level at which it is necessary to maintain improved level. At weakening the symptoms up to desired level one should stop therapy immediately. At any relapse of disease symptoms patients could need periodic therapy upon lasting basis.

EFFECT: higher efficiency of application.

2 cl, 3 ex, 3 tbl

FIELD: chemico-pharmaceutical industry.

SUBSTANCE: mixture A obtained due to mixing pre-reduced acetylsalicylic acid with a carrier and glucose followed by its diluting in aqueous-alcoholic solution should be mixed with mixture B obtained due to suspending calcium gluconate, plastifying and lipophilic agents in solvent, followed by deaeration of the mixture obtained, its application onto bottom plate with subsequent drying and forming the ready-to-use medicinal form. Method enables to obtain remedy of increased stability of functional characteristics, prolonged action and increased bioavailability of acetylsalicylic acid at no side effects.

EFFECT: higher efficiency.

3 ex

FIELD: veterinary science.

SUBSTANCE: the suggested preparation includes hexamethylene tetramine and salicylic acid at the following ratio of components, weight%: hexamethylene tetramine 45-55, salicylic acid 45-55. prophylactic efficiency corresponds to 94-96.5%, therapeutic efficiency corresponds to 97-98.2%.

EFFECT: higher efficiency of prophylaxis and therapy.

5 ex, 1 tbl

FIELD: medicine, cardiology.

SUBSTANCE: the present innovation deals with decreasing side effects of medicinal preparation of cardiotoxic component. For this purpose it is suggested to apply cariporide to decrease unfavorable impact of macrolide antibiotic, rulide, in particular. The innovation suggested provides the chance to remove side effects of macrolide antibiotic regarding patient's heart under conditions of ischemia and reperfusion.

EFFECT: higher efficiency of application.

2 tbl

FIELD: veterinary science.

SUBSTANCE: a sow should be twice injected with oxytocin and, additionally, intramuscularly about 2-4 h after afterbirth detachment one should introduce clathroprostin at the dosage of 1 ml. The innovation suggested is very efficient in preventing metritis-mastitis-agalactia and endometritis in sows, as well.

EFFECT: higher efficiency of prophylaxis.

1 ex, 1 tbl